Literature DB >> 3002299

Demonstration of non-degraded Aleutian disease virus (ADV) proteins in lung tissue from experimentally infected mink kits. Brief report.

S Alexandersen, A Uttenthal-Jensen, B Aasted.   

Abstract

Isolates of ADV replicate to rather high quantities in lungs from neonatally infected mink kits. The virus was analysed for polypeptide composition, and for the first time high molecular weight polypeptides have been observed in in vivo produced ADVs. These polypeptides are analogous to those of in vitro produced ADVs. The molecular weights of the structural polypeptides of the low virulence Pullman ADV and the highly virulent DK and Utah I isolates of ADV were found to be 88kD and 78kD and in vivo produced ADV-G polypeptides were found to be 85kD and 75kD, the same molecular weights as those described for in vitro produced ADV-G. Presence of the ADV coded, non-structural polypeptide with the molecular weight of 71kD (p71) was also demonstrated in the lung tissue from mink kits.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3002299     DOI: 10.1007/bf01310549

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  11 in total

1.  Characterisation of Aleutian disease antigens.

Authors:  G W Notani; E C Hahn; N H Sarkar; A J Kenyon
Journal:  Nature       Date:  1976-05-06       Impact factor: 49.962

2.  Development, characterization, and viral susceptibility of a feline (Felis catus) renal cell line (CRFK).

Authors:  R A Crandell; C G Fabricant; W A Nelson-Rees
Journal:  In Vitro       Date:  1973 Nov-Dec

3.  Serological analyses of different mink Aleutian disease virus strains.

Authors:  B Aasted; B Avery; A Cohn
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

4.  Characterization of Aleutian disease virus as a parvovirus.

Authors:  M E Bloom; R E Race; J B Wolfinbarger
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

5.  Propagation of Aleutian disease parvovirus in cell line CCC clone 81.

Authors:  S van Dawen; O R Kaaden; S Roth
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

6.  Rocket line immunoelectrophoresis: an improved assay for simultaneous quantification of a mink parvovirus (Aleutian disease virus) antigen and antibody.

Authors:  S Alexandersen; J Hau
Journal:  J Virol Methods       Date:  1985-02       Impact factor: 2.014

7.  Characterization of the protein and nucleic acid of Aleutian disease virus.

Authors:  M S Shahrabadi; H J Cho; R G Marusyk
Journal:  J Virol       Date:  1977-08       Impact factor: 5.103

8.  Inhibition of precipitation in counter current electrophoresis. A sensitive method for detection of mink antibodies to Aleutian disease virus.

Authors:  B Aasted; A Cohn
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1982-02

9.  Identification of a nonvirion protein of Aleutian disease virus: mink with Aleutian disease have antibody to both virion and nonvirion proteins.

Authors:  M E Bloom; R E Race; J B Wolfinbarger
Journal:  J Virol       Date:  1982-08       Impact factor: 5.103

10.  Aleutian disease virus, a parvovirus, is proteolytically degraded during in vivo infection in mink.

Authors:  B Aasted; R E Race; M E Bloom
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

View more
  19 in total

1.  Molecular comparisons of in vivo- and in vitro-derived strains of Aleutian disease of mink parvovirus.

Authors:  M E Bloom; O R Kaaden; E Huggans; A Cohn; J B Wolfinbarger
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

2.  Nucleotide sequence analysis of Aleutian mink disease parvovirus shows that multiple virus types are present in infected mink.

Authors:  E Gottschalck; S Alexandersen; A Cohn; L A Poulsen; M E Bloom; B Aasted
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  The transcription profile of Aleutian mink disease virus in CRFK cells is generated by alternative processing of pre-mRNAs produced from a single promoter.

Authors:  Jianming Qiu; Fang Cheng; Lisa R Burger; David Pintel
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

4.  Evidence of restricted viral replication in adult mink infected with Aleutian disease of mink parvovirus.

Authors:  S Alexandersen; M E Bloom; J Wolfinbarger
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

5.  Immunohistochemical detection of 3 viral infections in paraffin-embedded tissue from mink (Mustela vison): a tissue-microarray-based study.

Authors:  Anne Sofie Hammer; Hans Henrik Dietz; Stephen Hamilton-Dutoit
Journal:  Can J Vet Res       Date:  2007-01       Impact factor: 1.310

6.  Pathogenesis of Aleutian mink disease parvovirus infection: effects of suppression of antibody response on viral mRNA levels and on development of acute disease.

Authors:  S Alexandersen; T Storgaard; N Kamstrup; B Aasted; D D Porter
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

7.  In situ molecular hybridization for detection of Aleutian mink disease parvovirus DNA by using strand-specific probes: identification of target cells for viral replication in cell cultures and in mink kits with virus-induced interstitial pneumonia.

Authors:  S Alexandersen; M E Bloom; J Wolfinbarger; R E Race
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

8.  Characterization of chimeric full-length molecular clones of Aleutian mink disease parvovirus (ADV): identification of a determinant governing replication of ADV in cell culture.

Authors:  M E Bloom; B D Berry; W Wei; S Perryman; J B Wolfinbarger
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

9.  Sequence comparison of the non-structural genes of four different types of Aleutian mink disease parvovirus indicates an unusual degree of variability.

Authors:  E Gottschalck; S Alexandersen; T Storgaard; M E Bloom; B Aasted
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

10.  Topographical analysis of the G virion of Aleutian mink disease parvovirus with monoclonal antibodies.

Authors:  D L Barnard; F B Johnson
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.